James Basiliere

James Basiliere has a diverse work experience in various leadership roles. James is currently serving as the Sr. Director of Operations at Ortho Molecular Products since July 2020. Prior to that, they were the CEO of Basiliere Pharmaceutical LLC. starting from September 2019.

Before that, they worked as the Vice President at Wellnova Consumer Healthcare from May 2018 to September 2019. In this role, they spearheaded the launch of a new OTC unit dose product and managed contract management, operations, quality controls, and regulatory CMC Systems Development.

From May 2014 to May 2018, James Basiliere was the Vice President at Medline Industries, Inc. James oversaw plant performance and directed various teams to ensure cohesive workflow and implemented continuous improvement initiatives.

Before that, they held multiple roles at POET, including General Manager for Bingham Lake Minnesota and Ashton Iowa plants. During their time at POET, they managed plant operations, including manufacturing, engineering, finance, administration, quality, and maintenance teams, and presented business metrics to the Board.

Overall, James Basiliere has demonstrated their expertise in operations, leadership, and strategic planning throughout their career.

James Basiliere has a Bachelor of Science degree in Microbiology from Minnesota State University, Mankato. No specific start or end dates are provided for this education.